Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
SUMO4 is a member of the SUMO gene family. Zusätzlich bieten wir Ihnen SUMO4 Proteine (3) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 74 products:
Human Polyclonal SUMO4 Primary Antibody für IHC (p), WB - ABIN388077
Bohren, Nadkarni, Song, Gabbay, Owerbach: A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. in The Journal of biological chemistry 2004
Show all 5 Pubmed References
meta-analysis demonstrated that the G allele of the SUMO4 M55V polymorphism could be a susceptible risk locus to type 2 diabetes mellitus, mainly in the Chinese population, while the association in other ethnic population needs to be further validated
Both donor and recipient SUMO4 rs237025 polymorphisms contribute to the development of new-onset diabetes mellitus after liver transplantation.
Results show that SUMO-4 is expressed in normal placental development. SUMO-4 expression was increased in pre-eclamptic placentas and in models of oxidative stress and hypoxic injury suggesting that SUMO-4 hyper-SUMOylation may be a potential post-translational mechanism in the stressed pre-eclamptic placenta.
study suggests that SUMO4 c.163 G to A polymorphism is associated with the susceptibility to diabetic nephropathy in north Indian subjects with type 2 diabetes
SUMO4 M55V polymorphism and type-2 diabetes were significantly associated with a possible SUMO4 region to type-2 diabetes susceptibility.
No association between SUMO4 gene polymorphisms and acoronary artery disease with and without type 2 diabetes mellitus.
SUMO4 Met55Val variant was associated with increased insulin (zeige INS Antikörper) resistance in Chinese patients with newly diagnosed type 2 diabetes.
study demonstrates significant associations of SUMO4 M55V polymorphism with type 1 diabetes mellitus in Asian and Caucasian population and with type 2 diabetes mellitus in Asian population
The C438T polymorphism in the SUMO4 gene is associated with significantly increased risk of papulopustular skin lesions in HLA-B51-positive Behcet's disease patients.
This meta-analysis indicates that the SUMO4 M55V polymorphism confers susceptibility to type I diabetes in Asians and Europeans.
This gene is a member of the SUMO gene family. This family of genes encode small ubiquitin-related modifiers that are attached to proteins and control the target proteins' subcellular localization, stability, or activity. The protein described in this record is located in the cytoplasm and specifically modifies IKBA, leading to negative regulation of NF-kappa-B-dependent transcription of the IL12B gene. A specific polymorphism in this SUMO gene, which leads to the M55V substitution, has been associated with type I diabetes. The RefSeq contains this polymorphism.
SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae)
, small ubiquitin-related modifier 4
, SMT3 suppressor of mif two 3 homolog 2
, SMT3 suppressor of mif two 3 homolog 4
, small ubiquitin-like modifier 4 protein